These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38341869)

  • 1. Discovery and Synthesis of a Gram-Negative-Active Cationic Lipopeptide Antibiotic Inspired by Primary Sequences from Underexplored Gram-Negative Bacteria.
    Sun R; You R; Yu X; Zhao D; Li L
    Org Lett; 2024 Feb; 26(7):1348-1352. PubMed ID: 38341869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin.
    Lim AL; Miller BW; Lin Z; Fisher MA; Barrows LR; Haygood MG; Schmidt EW
    Microbiol Spectr; 2023 Dec; 11(6):e0230623. PubMed ID: 37882570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Paenibacillaceae Family Gram-Negative-Active Cationic Lipopeptide Antibiotics Using Evolution-Guided Chemical Synthesis.
    Wang Z; Koirala B; Hernandez Y; Brady SF
    Org Lett; 2022 Jul; 24(27):4943-4948. PubMed ID: 35776528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naturally inspired antibiotic to target multidrug-resistant pathogens.
    Wang Z; Koirala B; Hernandez Y; Zimmerman M; Park S; Perlin DS; Brady SF
    Nature; 2022 Jan; 601(7894):606-611. PubMed ID: 34987225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.
    Roberts KD; Zhu Y; Azad MAK; Han ML; Wang J; Wang L; Yu HH; Horne AS; Pinson JA; Rudd D; Voelcker NH; Patil NA; Zhao J; Jiang X; Lu J; Chen K; Lomovskaya O; Hecker SJ; Thompson PE; Nation RL; Dudley MN; Griffith DC; Velkov T; Li J
    Nat Commun; 2022 Mar; 13(1):1625. PubMed ID: 35338128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
    Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining.
    Li YX; Zhong Z; Zhang WP; Qian PY
    Nat Commun; 2018 Aug; 9(1):3273. PubMed ID: 30115920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
    Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
    J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
    Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters.
    Xu C; Liu C; Chen K; Zeng P; Chan EWC; Chen S
    Commun Biol; 2022 Jun; 5(1):613. PubMed ID: 35729200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin.
    Yao Z; Feng L; Zhao Y; Zhang X; Chen L; Wang L; Zhang Y; Sun Y; Zhou T; Cao J
    Microbiol Spectr; 2022 Aug; 10(4):e0018422. PubMed ID: 35700133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
    Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y
    Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.